SparingVision Conference Participation in H1 2023
Paris, January 31, 2023 – SparingVision (“the Company”), a genomic medicine company developing vision-saving treatments for ocular diseases, today announces the upcoming conferences that its management team will be participating in in the first half of 2023:
Investor and Industry Conferences:
2023 SVB Securities Global Biopharma Conference, Virtual – 31 January–2 February
Advanced Therapies Showcase in Tokyo #3, Virtual – 1 February
Advanced Therapies Congress, London, UK – 14-15 March
Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – 12-14 April
Bio€quity Europe 2023, Dublin, Ireland – 14-16 May
Scientific and Medical Conferences:
The Foundation Fighting Blindness’ Investing in the Cures Summit, Amelia Island, Florida, US – 10-11 February
Society of Toxicology (SOT) 62nd Annual Meeting, Nashville, Tennessee, US – 19-23 March
Chief Medical Officer Summit 360°, Boston, Massachusetts, US – 3-4 April
The Foundation Fighting Blindness’ Retinal Cell and Gene Therapy Innovation Summit, New Orleans, Louisiana – 20 April
The Association for Research in Vision and Ophthalmology (ARVO) 2023, New Orleans, Louisiana, US – 23-27 April
American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Los Angeles, California, US – 16-20 May
Patient Advocacy Conferences:
France Choroïdérémie, Paris, France – 18 March
Rare Disease Innovation & Partnering Summit, Philadelphia, Pennsylvania, US – 21-23 March
PRPH2 and Associated Retinal Diseases Workshop, San Diego, California, US – 29-31 March
**ENDS**